郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Pirfenidone for the treatment of idiopathic pulmonary fibrosis.

期刊：Expert opinion on investigational drugs发表年份：2006作者：Sabina A Antoniu
阅读更多 →

药效评价2-[(4-phenylpiperazin-1-yl)methyl]imidazo(di)azines as selective D4-ligands. Induction of penile erection by 2-[4-(2-methoxyphenyl)piperazin-1-ylmethyl]imidazo[1,2-a]pyridine (PIP3EA), a potent and selective D4 partial agonist.

期刊：Journal of medicinal chemistry发表年份：2006作者：Cécile Enguehard-Gueiffier; Harald Hübner; Ahmed El Hakmaoui; Hassan Allouchi; Peter Gmeiner; Antonio Argiolas; Maria Rosaria Melis; Alain Gueiffier
阅读更多 →

药效评价Evidence that translation reinitiation leads to a partially functional Menkes protein containing two copper-binding sites.

期刊：American journal of human genetics发表年份：2006作者：Marianne Paulsen; Connie Lund; Zarqa Akram; Jakob R Winther; Nina Horn; Lisbeth Birk Møller
阅读更多 →

药效评价Role of epidermal growth factor receptor transactivation in alpha1B-adrenoceptor phosphorylation.

期刊：European journal of pharmacology发表年份：2006作者：Patricia Casas-González; J Adolfo García-Sáinz
阅读更多 →